JP5726285B2 - チャージ強化神経電気刺激システム - Google Patents
チャージ強化神経電気刺激システム Download PDFInfo
- Publication number
- JP5726285B2 JP5726285B2 JP2013501261A JP2013501261A JP5726285B2 JP 5726285 B2 JP5726285 B2 JP 5726285B2 JP 2013501261 A JP2013501261 A JP 2013501261A JP 2013501261 A JP2013501261 A JP 2013501261A JP 5726285 B2 JP5726285 B2 JP 5726285B2
- Authority
- JP
- Japan
- Prior art keywords
- signal
- neural
- stimulation
- nerve
- electrode
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000000638 stimulation Effects 0.000 title claims description 519
- 230000001537 neural effect Effects 0.000 title claims description 510
- 210000005036 nerve Anatomy 0.000 claims description 315
- 210000003205 muscle Anatomy 0.000 claims description 184
- 210000000118 neural pathway Anatomy 0.000 claims description 172
- 230000010004 neural pathway Effects 0.000 claims description 169
- 230000005062 synaptic transmission Effects 0.000 claims description 145
- 241000251539 Vertebrata <Metazoa> Species 0.000 claims description 136
- 230000001965 increasing effect Effects 0.000 claims description 70
- 206010010904 Convulsion Diseases 0.000 claims description 58
- 230000036461 convulsion Effects 0.000 claims description 56
- 230000000737 periodic effect Effects 0.000 claims description 32
- 230000008054 signal transmission Effects 0.000 claims description 20
- 210000001044 sensory neuron Anatomy 0.000 claims description 18
- 230000001939 inductive effect Effects 0.000 claims description 17
- 230000001149 cognitive effect Effects 0.000 claims description 5
- 230000003287 optical effect Effects 0.000 claims description 4
- 238000012545 processing Methods 0.000 claims description 3
- 241001465754 Metazoa Species 0.000 description 136
- 230000005540 biological transmission Effects 0.000 description 131
- 210000000337 motor cortex Anatomy 0.000 description 130
- 210000002161 motor neuron Anatomy 0.000 description 121
- 230000000694 effects Effects 0.000 description 118
- 230000004044 response Effects 0.000 description 104
- 210000002569 neuron Anatomy 0.000 description 102
- 210000000278 spinal cord Anatomy 0.000 description 81
- 208000020431 spinal cord injury Diseases 0.000 description 81
- 238000000034 method Methods 0.000 description 75
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 72
- 208000035475 disorder Diseases 0.000 description 65
- 238000011282 treatment Methods 0.000 description 64
- 238000012360 testing method Methods 0.000 description 63
- 230000037361 pathway Effects 0.000 description 62
- 230000001054 cortical effect Effects 0.000 description 61
- 230000000763 evoking effect Effects 0.000 description 61
- 208000005392 Spasm Diseases 0.000 description 55
- 230000003447 ipsilateral effect Effects 0.000 description 54
- 208000014674 injury Diseases 0.000 description 50
- 238000002474 experimental method Methods 0.000 description 47
- 208000007101 Muscle Cramp Diseases 0.000 description 46
- 230000007433 nerve pathway Effects 0.000 description 46
- 230000000875 corresponding effect Effects 0.000 description 45
- 210000003414 extremity Anatomy 0.000 description 43
- 210000004556 brain Anatomy 0.000 description 40
- 230000010287 polarization Effects 0.000 description 39
- 230000001360 synchronised effect Effects 0.000 description 37
- 230000006378 damage Effects 0.000 description 35
- 230000008925 spontaneous activity Effects 0.000 description 34
- 210000004027 cell Anatomy 0.000 description 31
- 230000008859 change Effects 0.000 description 31
- 230000000630 rising effect Effects 0.000 description 30
- 230000001953 sensory effect Effects 0.000 description 30
- 208000027418 Wounds and injury Diseases 0.000 description 29
- 238000010304 firing Methods 0.000 description 29
- 230000033001 locomotion Effects 0.000 description 29
- 230000008569 process Effects 0.000 description 27
- 244000309466 calf Species 0.000 description 26
- 230000006870 function Effects 0.000 description 26
- 230000006872 improvement Effects 0.000 description 26
- 238000000540 analysis of variance Methods 0.000 description 25
- 230000006735 deficit Effects 0.000 description 25
- 208000024891 symptom Diseases 0.000 description 25
- 210000003141 lower extremity Anatomy 0.000 description 24
- 241000282414 Homo sapiens Species 0.000 description 23
- 206010033799 Paralysis Diseases 0.000 description 22
- 210000003618 cortical neuron Anatomy 0.000 description 22
- 230000008733 trauma Effects 0.000 description 22
- 210000003050 axon Anatomy 0.000 description 21
- 210000002972 tibial nerve Anatomy 0.000 description 21
- 210000000707 wrist Anatomy 0.000 description 21
- 238000011084 recovery Methods 0.000 description 20
- 238000012353 t test Methods 0.000 description 20
- 206010001497 Agitation Diseases 0.000 description 19
- 210000002414 leg Anatomy 0.000 description 19
- 238000000692 Student's t-test Methods 0.000 description 18
- 230000001976 improved effect Effects 0.000 description 18
- 230000004118 muscle contraction Effects 0.000 description 18
- 241000699670 Mus sp. Species 0.000 description 16
- 210000000860 cochlear nerve Anatomy 0.000 description 16
- 230000001771 impaired effect Effects 0.000 description 16
- 230000007246 mechanism Effects 0.000 description 16
- 230000002232 neuromuscular Effects 0.000 description 16
- 210000001519 tissue Anatomy 0.000 description 16
- 210000005250 spinal neuron Anatomy 0.000 description 14
- 230000002269 spontaneous effect Effects 0.000 description 14
- 210000003926 auditory cortex Anatomy 0.000 description 13
- 238000010586 diagram Methods 0.000 description 13
- 230000002102 hyperpolarization Effects 0.000 description 13
- 230000028161 membrane depolarization Effects 0.000 description 13
- 230000002829 reductive effect Effects 0.000 description 13
- 210000000857 visual cortex Anatomy 0.000 description 13
- 241000699666 Mus <mouse, genus> Species 0.000 description 12
- 230000002920 convulsive effect Effects 0.000 description 12
- 230000008904 neural response Effects 0.000 description 12
- 210000001328 optic nerve Anatomy 0.000 description 12
- 210000002027 skeletal muscle Anatomy 0.000 description 12
- 241000282412 Homo Species 0.000 description 11
- 230000004913 activation Effects 0.000 description 11
- 210000003169 central nervous system Anatomy 0.000 description 11
- 230000004064 dysfunction Effects 0.000 description 11
- 210000001652 frontal lobe Anatomy 0.000 description 11
- 210000003128 head Anatomy 0.000 description 11
- 210000001153 interneuron Anatomy 0.000 description 11
- 210000001152 parietal lobe Anatomy 0.000 description 11
- 230000003518 presynaptic effect Effects 0.000 description 11
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 10
- 238000007427 paired t-test Methods 0.000 description 10
- 210000004885 white matter Anatomy 0.000 description 10
- 230000007423 decrease Effects 0.000 description 9
- 210000002683 foot Anatomy 0.000 description 9
- 230000007274 generation of a signal involved in cell-cell signaling Effects 0.000 description 9
- 238000005259 measurement Methods 0.000 description 9
- 230000002441 reversible effect Effects 0.000 description 9
- 210000003625 skull Anatomy 0.000 description 9
- 230000004936 stimulating effect Effects 0.000 description 9
- 238000005728 strengthening Methods 0.000 description 9
- 230000000946 synaptic effect Effects 0.000 description 9
- 208000020339 Spinal injury Diseases 0.000 description 8
- 230000005856 abnormality Effects 0.000 description 8
- 230000009471 action Effects 0.000 description 8
- 238000004458 analytical method Methods 0.000 description 8
- 210000001787 dendrite Anatomy 0.000 description 8
- 238000001514 detection method Methods 0.000 description 8
- 230000002964 excitative effect Effects 0.000 description 8
- 230000002068 genetic effect Effects 0.000 description 8
- 238000002513 implantation Methods 0.000 description 8
- WABPQHHGFIMREM-UHFFFAOYSA-N lead(0) Chemical compound [Pb] WABPQHHGFIMREM-UHFFFAOYSA-N 0.000 description 8
- 239000012528 membrane Substances 0.000 description 8
- 230000009467 reduction Effects 0.000 description 8
- 230000004043 responsiveness Effects 0.000 description 8
- 241000700159 Rattus Species 0.000 description 7
- 210000005056 cell body Anatomy 0.000 description 7
- 230000003247 decreasing effect Effects 0.000 description 7
- 230000002708 enhancing effect Effects 0.000 description 7
- 210000000653 nervous system Anatomy 0.000 description 7
- 210000000578 peripheral nerve Anatomy 0.000 description 7
- 238000010149 post-hoc-test Methods 0.000 description 7
- 230000001242 postsynaptic effect Effects 0.000 description 7
- 210000005172 vertebrate brain Anatomy 0.000 description 7
- 208000012902 Nervous system disease Diseases 0.000 description 6
- 208000025966 Neurological disease Diseases 0.000 description 6
- 208000029560 autism spectrum disease Diseases 0.000 description 6
- 230000008602 contraction Effects 0.000 description 6
- 230000009395 genetic defect Effects 0.000 description 6
- 230000002401 inhibitory effect Effects 0.000 description 6
- 239000002858 neurotransmitter agent Substances 0.000 description 6
- 230000036961 partial effect Effects 0.000 description 6
- 210000004345 peroneal nerve Anatomy 0.000 description 6
- 238000013105 post hoc analysis Methods 0.000 description 6
- 210000001525 retina Anatomy 0.000 description 6
- 239000000523 sample Substances 0.000 description 6
- 238000010998 test method Methods 0.000 description 6
- 238000002604 ultrasonography Methods 0.000 description 6
- 239000004471 Glycine Substances 0.000 description 5
- YQEZLKZALYSWHR-UHFFFAOYSA-N Ketamine Chemical compound C=1C=CC=C(Cl)C=1C1(NC)CCCCC1=O YQEZLKZALYSWHR-UHFFFAOYSA-N 0.000 description 5
- 208000006011 Stroke Diseases 0.000 description 5
- 230000036982 action potential Effects 0.000 description 5
- 206010002026 amyotrophic lateral sclerosis Diseases 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- 230000015556 catabolic process Effects 0.000 description 5
- 239000002131 composite material Substances 0.000 description 5
- 230000008878 coupling Effects 0.000 description 5
- 238000010168 coupling process Methods 0.000 description 5
- 238000005859 coupling reaction Methods 0.000 description 5
- 238000006731 degradation reaction Methods 0.000 description 5
- 230000001419 dependent effect Effects 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 229960003299 ketamine Drugs 0.000 description 5
- 208000037805 labour Diseases 0.000 description 5
- 238000012544 monitoring process Methods 0.000 description 5
- 230000007514 neuronal growth Effects 0.000 description 5
- 210000003497 sciatic nerve Anatomy 0.000 description 5
- 210000000225 synapse Anatomy 0.000 description 5
- 208000011580 syndromic disease Diseases 0.000 description 5
- 206010002091 Anaesthesia Diseases 0.000 description 4
- 102000005915 GABA Receptors Human genes 0.000 description 4
- 108010005551 GABA Receptors Proteins 0.000 description 4
- 102000011714 Glycine Receptors Human genes 0.000 description 4
- 108010076533 Glycine Receptors Proteins 0.000 description 4
- 206010037714 Quadriplegia Diseases 0.000 description 4
- 230000037005 anaesthesia Effects 0.000 description 4
- 210000000617 arm Anatomy 0.000 description 4
- 230000003542 behavioural effect Effects 0.000 description 4
- 210000000459 calcaneus Anatomy 0.000 description 4
- 230000010261 cell growth Effects 0.000 description 4
- 206010008129 cerebral palsy Diseases 0.000 description 4
- 230000005684 electric field Effects 0.000 description 4
- 230000036749 excitatory postsynaptic potential Effects 0.000 description 4
- 210000003099 femoral nerve Anatomy 0.000 description 4
- 238000005286 illumination Methods 0.000 description 4
- 210000003127 knee Anatomy 0.000 description 4
- 230000005923 long-lasting effect Effects 0.000 description 4
- 210000001087 myotubule Anatomy 0.000 description 4
- 238000001543 one-way ANOVA Methods 0.000 description 4
- 230000010355 oscillation Effects 0.000 description 4
- 102000005962 receptors Human genes 0.000 description 4
- 108020003175 receptors Proteins 0.000 description 4
- 230000008929 regeneration Effects 0.000 description 4
- 238000011069 regeneration method Methods 0.000 description 4
- 230000033764 rhythmic process Effects 0.000 description 4
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 4
- QMGVPVSNSZLJIA-FVWCLLPLSA-N strychnine Chemical compound O([C@H]1CC(N([C@H]2[C@H]1[C@H]1C3)C=4C5=CC=CC=4)=O)CC=C1CN1[C@@H]3[C@]25CC1 QMGVPVSNSZLJIA-FVWCLLPLSA-N 0.000 description 4
- 230000007704 transition Effects 0.000 description 4
- 230000000007 visual effect Effects 0.000 description 4
- BPICBUSOMSTKRF-UHFFFAOYSA-N xylazine Chemical compound CC1=CC=CC(C)=C1NC1=NCCCS1 BPICBUSOMSTKRF-UHFFFAOYSA-N 0.000 description 4
- 229960001600 xylazine Drugs 0.000 description 4
- 208000034656 Contusions Diseases 0.000 description 3
- 238000010867 Hoechst staining Methods 0.000 description 3
- 208000016285 Movement disease Diseases 0.000 description 3
- 206010028289 Muscle atrophy Diseases 0.000 description 3
- 208000009205 Tinnitus Diseases 0.000 description 3
- 210000001015 abdomen Anatomy 0.000 description 3
- 230000002159 abnormal effect Effects 0.000 description 3
- 210000003423 ankle Anatomy 0.000 description 3
- 230000003376 axonal effect Effects 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 210000003850 cellular structure Anatomy 0.000 description 3
- 210000003710 cerebral cortex Anatomy 0.000 description 3
- 230000002596 correlated effect Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000035784 germination Effects 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 244000144993 groups of animals Species 0.000 description 3
- 239000007943 implant Substances 0.000 description 3
- 210000001926 inhibitory interneuron Anatomy 0.000 description 3
- 230000000977 initiatory effect Effects 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 230000003993 interaction Effects 0.000 description 3
- 229910052741 iridium Inorganic materials 0.000 description 3
- GKOZUEZYRPOHIO-UHFFFAOYSA-N iridium atom Chemical compound [Ir] GKOZUEZYRPOHIO-UHFFFAOYSA-N 0.000 description 3
- 238000002684 laminectomy Methods 0.000 description 3
- 230000003902 lesion Effects 0.000 description 3
- 230000027928 long-term synaptic potentiation Effects 0.000 description 3
- 230000000926 neurological effect Effects 0.000 description 3
- 230000003534 oscillatory effect Effects 0.000 description 3
- 210000004197 pelvis Anatomy 0.000 description 3
- 230000002093 peripheral effect Effects 0.000 description 3
- 210000001428 peripheral nervous system Anatomy 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 210000004129 prosencephalon Anatomy 0.000 description 3
- 230000003252 repetitive effect Effects 0.000 description 3
- 210000001202 rhombencephalon Anatomy 0.000 description 3
- 230000009195 sensorimotor pathway Effects 0.000 description 3
- 230000019491 signal transduction Effects 0.000 description 3
- 230000002739 subcortical effect Effects 0.000 description 3
- 230000001629 suppression Effects 0.000 description 3
- 210000002435 tendon Anatomy 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 231100000886 tinnitus Toxicity 0.000 description 3
- 238000012549 training Methods 0.000 description 3
- LHYQAEFVHIZFLR-UHFFFAOYSA-L 4-(4-diazonio-3-methoxyphenyl)-2-methoxybenzenediazonium;dichloride Chemical compound [Cl-].[Cl-].C1=C([N+]#N)C(OC)=CC(C=2C=C(OC)C([N+]#N)=CC=2)=C1 LHYQAEFVHIZFLR-UHFFFAOYSA-L 0.000 description 2
- 208000024827 Alzheimer disease Diseases 0.000 description 2
- 206010005177 Blindness cortical Diseases 0.000 description 2
- 244000025254 Cannabis sativa Species 0.000 description 2
- 108091006146 Channels Proteins 0.000 description 2
- 206010009346 Clonus Diseases 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- 206010049816 Muscle tightness Diseases 0.000 description 2
- 206010029174 Nerve compression Diseases 0.000 description 2
- 208000028389 Nerve injury Diseases 0.000 description 2
- QMGVPVSNSZLJIA-UHFFFAOYSA-N Nux Vomica Natural products C1C2C3C4N(C=5C6=CC=CC=5)C(=O)CC3OCC=C2CN2C1C46CC2 QMGVPVSNSZLJIA-UHFFFAOYSA-N 0.000 description 2
- 229930040373 Paraformaldehyde Natural products 0.000 description 2
- 206010033892 Paraplegia Diseases 0.000 description 2
- 206010054808 Peripheral paralysis Diseases 0.000 description 2
- LHNKBXRFNPMIBR-UHFFFAOYSA-N Picrotoxin Natural products CC(C)(O)C1(O)C2OC(=O)C1C3(O)C4OC4C5C(=O)OC2C35C LHNKBXRFNPMIBR-UHFFFAOYSA-N 0.000 description 2
- 208000008765 Sciatica Diseases 0.000 description 2
- 241001279009 Strychnos toxifera Species 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 208000030886 Traumatic Brain injury Diseases 0.000 description 2
- 210000003489 abdominal muscle Anatomy 0.000 description 2
- 230000002730 additional effect Effects 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 230000002238 attenuated effect Effects 0.000 description 2
- 230000003190 augmentative effect Effects 0.000 description 2
- 230000036770 blood supply Effects 0.000 description 2
- 208000034526 bruise Diseases 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 210000000038 chest Anatomy 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 230000003138 coordinated effect Effects 0.000 description 2
- 208000009153 cortical blindness Diseases 0.000 description 2
- 238000007405 data analysis Methods 0.000 description 2
- 238000013481 data capture Methods 0.000 description 2
- 230000001934 delay Effects 0.000 description 2
- 230000003111 delayed effect Effects 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 230000006866 deterioration Effects 0.000 description 2
- 238000006073 displacement reaction Methods 0.000 description 2
- 210000001951 dura mater Anatomy 0.000 description 2
- 210000003027 ear inner Anatomy 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 210000003194 forelimb Anatomy 0.000 description 2
- 238000013467 fragmentation Methods 0.000 description 2
- 238000006062 fragmentation reaction Methods 0.000 description 2
- 210000004884 grey matter Anatomy 0.000 description 2
- 210000004247 hand Anatomy 0.000 description 2
- 210000001624 hip Anatomy 0.000 description 2
- 230000000971 hippocampal effect Effects 0.000 description 2
- 210000005082 ipsilateral motoneuron Anatomy 0.000 description 2
- 230000009180 ipsilateral muscle contraction Effects 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 230000002045 lasting effect Effects 0.000 description 2
- 231100000636 lethal dose Toxicity 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000004660 morphological change Effects 0.000 description 2
- 230000001095 motoneuron effect Effects 0.000 description 2
- 201000006417 multiple sclerosis Diseases 0.000 description 2
- 230000020763 muscle atrophy Effects 0.000 description 2
- 201000000585 muscular atrophy Diseases 0.000 description 2
- 210000003739 neck Anatomy 0.000 description 2
- 230000008035 nerve activity Effects 0.000 description 2
- 230000008764 nerve damage Effects 0.000 description 2
- 230000007383 nerve stimulation Effects 0.000 description 2
- 230000004766 neurogenesis Effects 0.000 description 2
- 230000008062 neuronal firing Effects 0.000 description 2
- 201000001119 neuropathy Diseases 0.000 description 2
- 230000007823 neuropathy Effects 0.000 description 2
- 230000003957 neurotransmitter release Effects 0.000 description 2
- 230000008520 organization Effects 0.000 description 2
- 229920002866 paraformaldehyde Polymers 0.000 description 2
- 208000033808 peripheral neuropathy Diseases 0.000 description 2
- 230000000704 physical effect Effects 0.000 description 2
- 230000035790 physiological processes and functions Effects 0.000 description 2
- VJKUPQSHOVKBCO-AHMKVGDJSA-N picrotoxin Chemical compound O=C([C@@]12O[C@@H]1C[C@]1(O)[C@@]32C)O[C@@H]3[C@H]2[C@@H](C(=C)C)[C@@H]1C(=O)O2.O=C([C@@]12O[C@@H]1C[C@]1(O)[C@@]32C)O[C@@H]3[C@H]2[C@@H](C(C)(O)C)[C@@H]1C(=O)O2 VJKUPQSHOVKBCO-AHMKVGDJSA-N 0.000 description 2
- 229920000729 poly(L-lysine) polymer Polymers 0.000 description 2
- 230000002035 prolonged effect Effects 0.000 description 2
- 238000011002 quantification Methods 0.000 description 2
- 210000002979 radial nerve Anatomy 0.000 description 2
- 230000011514 reflex Effects 0.000 description 2
- 230000002787 reinforcement Effects 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 230000001020 rhythmical effect Effects 0.000 description 2
- 230000037152 sensory function Effects 0.000 description 2
- 230000008786 sensory perception of smell Effects 0.000 description 2
- 238000004088 simulation Methods 0.000 description 2
- 230000001148 spastic effect Effects 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- 229910001220 stainless steel Inorganic materials 0.000 description 2
- 239000010935 stainless steel Substances 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- 229960005453 strychnine Drugs 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 210000000115 thoracic cavity Anatomy 0.000 description 2
- 230000001550 time effect Effects 0.000 description 2
- 210000003371 toe Anatomy 0.000 description 2
- 210000005010 torso Anatomy 0.000 description 2
- 230000001052 transient effect Effects 0.000 description 2
- 230000009529 traumatic brain injury Effects 0.000 description 2
- 230000001960 triggered effect Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 1
- RDEIXVOBVLKYNT-VQBXQJRRSA-N (2r,3r,4r,5r)-2-[(1s,2s,3r,4s,6r)-4,6-diamino-3-[(2r,3r,6s)-3-amino-6-(1-aminoethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol;(2r,3r,4r,5r)-2-[(1s,2s,3r,4s,6r)-4,6-diamino-3-[(2r,3r,6s)-3-amino-6-(aminomethyl)oxan-2-yl]o Chemical compound OS(O)(=O)=O.O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H](CC[C@@H](CN)O2)N)[C@@H](N)C[C@H]1N.O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H](CC[C@H](O2)C(C)N)N)[C@@H](N)C[C@H]1N.O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N RDEIXVOBVLKYNT-VQBXQJRRSA-N 0.000 description 1
- 208000014825 Abnormal muscle tone Diseases 0.000 description 1
- 101000768857 Arabidopsis thaliana 3-phosphoshikimate 1-carboxyvinyltransferase, chloroplastic Proteins 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 206010003805 Autism Diseases 0.000 description 1
- 208000020706 Autistic disease Diseases 0.000 description 1
- 208000014644 Brain disease Diseases 0.000 description 1
- 208000031404 Chromosome Aberrations Diseases 0.000 description 1
- 208000032131 Diabetic Neuropathies Diseases 0.000 description 1
- 241001269524 Dura Species 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 102000018899 Glutamate Receptors Human genes 0.000 description 1
- 108010027915 Glutamate Receptors Proteins 0.000 description 1
- 208000023105 Huntington disease Diseases 0.000 description 1
- 108010048829 Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels Proteins 0.000 description 1
- 102000009453 Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels Human genes 0.000 description 1
- 108090000862 Ion Channels Proteins 0.000 description 1
- 102000004310 Ion Channels Human genes 0.000 description 1
- 238000001282 Kruskal–Wallis one-way analysis of variance Methods 0.000 description 1
- 206010024229 Leprosy Diseases 0.000 description 1
- 208000016604 Lyme disease Diseases 0.000 description 1
- 208000008238 Muscle Spasticity Diseases 0.000 description 1
- 102000004868 N-Methyl-D-Aspartate Receptors Human genes 0.000 description 1
- 108090001041 N-Methyl-D-Aspartate Receptors Proteins 0.000 description 1
- HOKKHZGPKSLGJE-GSVOUGTGSA-N N-Methyl-D-aspartic acid Chemical compound CN[C@@H](C(O)=O)CC(O)=O HOKKHZGPKSLGJE-GSVOUGTGSA-N 0.000 description 1
- 150000001200 N-acyl ethanolamides Chemical class 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 208000006289 Rett Syndrome Diseases 0.000 description 1
- 241000220010 Rhode Species 0.000 description 1
- 241000283984 Rodentia Species 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 206010039966 Senile dementia Diseases 0.000 description 1
- 208000020764 Sensation disease Diseases 0.000 description 1
- 208000029033 Spinal Cord disease Diseases 0.000 description 1
- 102000003691 T-Type Calcium Channels Human genes 0.000 description 1
- 108090000030 T-Type Calcium Channels Proteins 0.000 description 1
- 241000270666 Testudines Species 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- ZHAFUINZIZIXFC-UHFFFAOYSA-N [9-(dimethylamino)-10-methylbenzo[a]phenoxazin-5-ylidene]azanium;chloride Chemical compound [Cl-].O1C2=CC(=[NH2+])C3=CC=CC=C3C2=NC2=C1C=C(N(C)C)C(C)=C2 ZHAFUINZIZIXFC-UHFFFAOYSA-N 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- VREFGVBLTWBCJP-UHFFFAOYSA-N alprazolam Chemical compound C12=CC(Cl)=CC=C2N2C(C)=NN=C2CN=C1C1=CC=CC=C1 VREFGVBLTWBCJP-UHFFFAOYSA-N 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 238000013528 artificial neural network Methods 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 230000010442 axonal sprouting Effects 0.000 description 1
- 230000028600 axonogenesis Effects 0.000 description 1
- 231100000871 behavioral problem Toxicity 0.000 description 1
- 238000009227 behaviour therapy Methods 0.000 description 1
- 230000002457 bidirectional effect Effects 0.000 description 1
- 230000002146 bilateral effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 230000007177 brain activity Effects 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000007248 cellular mechanism Effects 0.000 description 1
- 210000001638 cerebellum Anatomy 0.000 description 1
- 230000003920 cognitive function Effects 0.000 description 1
- 230000024391 collateral sprouting Effects 0.000 description 1
- 230000002301 combined effect Effects 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 238000004590 computer program Methods 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 239000004020 conductor Substances 0.000 description 1
- 210000005083 contralateral motoneuron Anatomy 0.000 description 1
- 230000002594 corticospinal effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 230000002999 depolarising effect Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 230000030808 detection of mechanical stimulus involved in sensory perception of sound Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 210000000624 ear auricle Anatomy 0.000 description 1
- 238000004070 electrodeposition Methods 0.000 description 1
- 238000005868 electrolysis reaction Methods 0.000 description 1
- 238000005421 electrostatic potential Methods 0.000 description 1
- 239000002621 endocannabinoid Substances 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000013401 experimental design Methods 0.000 description 1
- 210000002468 fat body Anatomy 0.000 description 1
- 229960003692 gamma aminobutyric acid Drugs 0.000 description 1
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 1
- 210000000609 ganglia Anatomy 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 210000000474 heel Anatomy 0.000 description 1
- 210000001320 hippocampus Anatomy 0.000 description 1
- 230000001744 histochemical effect Effects 0.000 description 1
- 238000010166 immunofluorescence Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000003137 locomotive effect Effects 0.000 description 1
- 210000004705 lumbosacral region Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 230000012241 membrane hyperpolarization Effects 0.000 description 1
- 102000006239 metabotropic receptors Human genes 0.000 description 1
- 108020004083 metabotropic receptors Proteins 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 230000037023 motor activity Effects 0.000 description 1
- 239000012120 mounting media Substances 0.000 description 1
- 210000001640 nerve ending Anatomy 0.000 description 1
- 210000004126 nerve fiber Anatomy 0.000 description 1
- 230000007971 neurological deficit Effects 0.000 description 1
- 208000018360 neuromuscular disease Diseases 0.000 description 1
- 210000000715 neuromuscular junction Anatomy 0.000 description 1
- 230000008284 neuronal mechanism Effects 0.000 description 1
- 230000005015 neuronal process Effects 0.000 description 1
- 231100000344 non-irritating Toxicity 0.000 description 1
- 229960002748 norepinephrine Drugs 0.000 description 1
- SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 230000036407 pain Effects 0.000 description 1
- 230000037324 pain perception Effects 0.000 description 1
- 230000001936 parietal effect Effects 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 238000010587 phase diagram Methods 0.000 description 1
- 235000020004 porter Nutrition 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 210000000063 presynaptic terminal Anatomy 0.000 description 1
- 210000000976 primary motor cortex Anatomy 0.000 description 1
- 230000007420 reactivation Effects 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000008521 reorganization Effects 0.000 description 1
- 230000001718 repressive effect Effects 0.000 description 1
- 230000036387 respiratory rate Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000003643 rhythmogenic effect Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 230000021317 sensory perception Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229940076279 serotonin Drugs 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 201000008425 spastic quadriplegia Diseases 0.000 description 1
- 208000031409 spastic quadriplegic cerebral palsy Diseases 0.000 description 1
- 208000018198 spasticity Diseases 0.000 description 1
- 238000012421 spiking Methods 0.000 description 1
- 210000000273 spinal nerve root Anatomy 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000000153 supplemental effect Effects 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 230000009782 synaptic response Effects 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 230000036962 time dependent Effects 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 210000001364 upper extremity Anatomy 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
- 230000002747 voluntary effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/36014—External stimulators, e.g. with patch electrodes
- A61N1/36017—External stimulators, e.g. with patch electrodes with leads or electrodes penetrating the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/0404—Electrodes for external use
- A61N1/0408—Use-related aspects
- A61N1/0452—Specially adapted for transcutaneous muscle stimulation [TMS]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/0404—Electrodes for external use
- A61N1/0408—Use-related aspects
- A61N1/0456—Specially adapted for transcutaneous electrical nerve stimulation [TENS]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
- A61N1/0504—Subcutaneous electrodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
- A61N1/0551—Spinal or peripheral nerve electrodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
- A61N1/0551—Spinal or peripheral nerve electrodes
- A61N1/0558—Anchoring or fixation means therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/08—Arrangements or circuits for monitoring, protecting, controlling or indicating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/36003—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation of motor muscles, e.g. for walking assistance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/36014—External stimulators, e.g. with patch electrodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/36014—External stimulators, e.g. with patch electrodes
- A61N1/36021—External stimulators, e.g. with patch electrodes for treatment of pain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/36014—External stimulators, e.g. with patch electrodes
- A61N1/3603—Control systems
- A61N1/36034—Control systems specified by the stimulation parameters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/3606—Implantable neurostimulators for stimulating central or peripheral nerve system adapted for a particular treatment
- A61N1/36067—Movement disorders, e.g. tremor or Parkinson disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/3606—Implantable neurostimulators for stimulating central or peripheral nerve system adapted for a particular treatment
- A61N1/36103—Neuro-rehabilitation; Repair or reorganisation of neural tissue, e.g. after stroke
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/36128—Control systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/36128—Control systems
- A61N1/36135—Control systems using physiological parameters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/36128—Control systems
- A61N1/36146—Control systems specified by the stimulation parameters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/36128—Control systems
- A61N1/36146—Control systems specified by the stimulation parameters
- A61N1/3615—Intensity
- A61N1/36153—Voltage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/36128—Control systems
- A61N1/36146—Control systems specified by the stimulation parameters
- A61N1/3615—Intensity
- A61N1/36157—Current
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/36128—Control systems
- A61N1/36146—Control systems specified by the stimulation parameters
- A61N1/3615—Intensity
- A61N1/3616—Voltage density or current density
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/36128—Control systems
- A61N1/36146—Control systems specified by the stimulation parameters
- A61N1/36167—Timing, e.g. stimulation onset
- A61N1/36175—Pulse width or duty cycle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/36128—Control systems
- A61N1/36146—Control systems specified by the stimulation parameters
- A61N1/36167—Timing, e.g. stimulation onset
- A61N1/36178—Burst or pulse train parameters
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Biophysics (AREA)
- Rehabilitation Therapy (AREA)
- Cardiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physiology (AREA)
- Hospice & Palliative Care (AREA)
- Electrotherapy Devices (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US31631910P | 2010-03-22 | 2010-03-22 | |
| US61/316,319 | 2010-03-22 | ||
| USPCT/US2010/053720 | 2010-10-22 | ||
| PCT/US2010/053720 WO2011050255A2 (en) | 2009-10-22 | 2010-10-22 | Dipole electrical stimulation employing direct current for recovery from spinal cord injury |
| PCT/US2011/022283 WO2011119251A2 (en) | 2010-03-22 | 2011-01-24 | Charge-enhanced neural electric stimulation system |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015071611A Division JP6062990B2 (ja) | 2010-03-22 | 2015-03-31 | チャージ強化神経電気刺激システム |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013521979A JP2013521979A (ja) | 2013-06-13 |
| JP2013521979A5 JP2013521979A5 (cg-RX-API-DMAC7.html) | 2014-03-13 |
| JP5726285B2 true JP5726285B2 (ja) | 2015-05-27 |
Family
ID=44673795
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013501261A Active JP5726285B2 (ja) | 2010-03-22 | 2011-01-24 | チャージ強化神経電気刺激システム |
| JP2015071611A Expired - Fee Related JP6062990B2 (ja) | 2010-03-22 | 2015-03-31 | チャージ強化神経電気刺激システム |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015071611A Expired - Fee Related JP6062990B2 (ja) | 2010-03-22 | 2015-03-31 | チャージ強化神経電気刺激システム |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20130035745A1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP5726285B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR101866252B1 (cg-RX-API-DMAC7.html) |
| CN (2) | CN105477782B (cg-RX-API-DMAC7.html) |
| CA (1) | CA2829189A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL222033A (cg-RX-API-DMAC7.html) |
| MX (2) | MX2012010841A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2011119251A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (149)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8932195B2 (en) | 2006-06-30 | 2015-01-13 | Research Foundation Of The City University Of New York | Process and apparatus for improving neuronal performance |
| US9008781B2 (en) | 2009-10-22 | 2015-04-14 | The Research Foundation Of The City University Of New York | Method and system for treatment of mobility dysfunction |
| US20130053922A1 (en) | 2009-10-22 | 2013-02-28 | Zaghloul Ahmed | Dipole electrical stimulation employing direct current for recovery from spinal cord injury |
| WO2012051495A2 (en) | 2010-10-15 | 2012-04-19 | The Research Foundation Of State University Of New York | Compositions and methods for enhancing the biological response to chemical agents and physical stimuli |
| CA2823592C (en) | 2011-01-03 | 2021-11-23 | The Regents Of The University Of California | High density epidural stimulation for facilitation of locomotion, posture, voluntary movement, and recovery of autonomic, sexual, vasomotor, and cognitive function after neurological injury |
| CN107361741B (zh) | 2011-03-24 | 2021-03-09 | 加利福尼亚理工学院 | 神经刺激器装置 |
| US9974455B2 (en) | 2011-05-13 | 2018-05-22 | Saluda Medical Pty Ltd. | Method and apparatus for estimating neural recruitment |
| US10568559B2 (en) | 2011-05-13 | 2020-02-25 | Saluda Medical Pty Ltd | Method and apparatus for measurement of neural response |
| US9872990B2 (en) | 2011-05-13 | 2018-01-23 | Saluda Medical Pty Limited | Method and apparatus for application of a neural stimulus |
| WO2012155190A1 (en) | 2011-05-13 | 2012-11-22 | National Ict Australia Ltd | Method and apparatus for measurement of neural response |
| JP6096759B2 (ja) | 2011-05-13 | 2017-03-15 | サルーダ・メディカル・ピーティーワイ・リミテッド | 神経応答の測定のための方法および装置 |
| WO2013071307A1 (en) | 2011-11-11 | 2013-05-16 | Edgerton Victor Reggie | Non invasive neuromodulation device for enabling recovery of motor, sensory, autonomic, sexual, vasomotor and cognitive function |
| US10092750B2 (en) | 2011-11-11 | 2018-10-09 | Neuroenabling Technologies, Inc. | Transcutaneous neuromodulation system and methods of using same |
| CA2876297C (en) | 2012-06-15 | 2019-02-26 | Case Western Reserve University | Therapy delivery devices and methods for non-damaging neural tissue conduction block |
| US10195434B2 (en) | 2012-06-15 | 2019-02-05 | Case Western Reserve University | Treatment of pain using electrical nerve conduction block |
| US9833614B1 (en) | 2012-06-22 | 2017-12-05 | Nevro Corp. | Autonomic nervous system control via high frequency spinal cord modulation, and associated systems and methods |
| DE102012013534B3 (de) | 2012-07-05 | 2013-09-19 | Tobias Sokolowski | Vorrichtung für repetitive Nervenstimulation zum Abbau von Fettgewebe mittels induktiver Magnetfelder |
| CN102886102B (zh) * | 2012-09-25 | 2014-12-10 | 深圳英智科技有限公司 | 镜像运动神经调制系统 |
| DK2908905T3 (da) | 2012-11-06 | 2020-12-14 | Saluda Medical Pty Ltd | System til at kontrollere elektriske forhold i væv |
| WO2014071445A1 (en) | 2012-11-06 | 2014-05-15 | Saluda Medical Pty Ltd | Method and system for controlling electrical conditions of tissue |
| CN103099677B (zh) * | 2013-01-17 | 2016-05-11 | 杨明亮 | 一种在生物体内构建网络及通过网络释放周期信号的方法 |
| US12453853B2 (en) * | 2013-01-21 | 2025-10-28 | Cala Health, Inc. | Multi-modal stimulation for treating tremor |
| CN105142714B (zh) | 2013-01-21 | 2018-02-16 | 卡拉健康公司 | 用于控制震颤的设备和方法 |
| DK2964315T3 (da) * | 2013-03-07 | 2019-01-02 | Univ City New York Res Found | System til behandling af neuromotorisk dysfunktion |
| EP3878507A1 (en) | 2013-03-15 | 2021-09-15 | The Regents Of The University Of California | Multi-site transcutaneous electrical stimulation of the spinal cord for facilitation of locomotion |
| US20150238764A1 (en) | 2013-05-10 | 2015-08-27 | Case Western Reserve University | Systems and methods for preventing noise in an electric waveform for neural stimulation, block, or sensing |
| JP6210363B2 (ja) * | 2013-05-24 | 2017-10-11 | 株式会社安川電機 | 訓練装置 |
| JP6210364B2 (ja) * | 2013-05-24 | 2017-10-11 | 株式会社安川電機 | 訓練装置 |
| US11229789B2 (en) | 2013-05-30 | 2022-01-25 | Neurostim Oab, Inc. | Neuro activator with controller |
| PL3003473T3 (pl) | 2013-05-30 | 2019-05-31 | Neurostim Solutions LLC | Miejscowa stymulacja neurologiczna |
| CN103495260B (zh) * | 2013-06-04 | 2016-05-25 | 东南大学 | 一种基于肌电信号和传感器信号实现精细实时运动的控制方法 |
| KR101540273B1 (ko) * | 2013-08-07 | 2015-07-31 | 한국과학기술연구원 | 멀티채널 촉각 유도 뇌 자극 |
| EP3049148B1 (en) | 2013-09-27 | 2020-05-20 | The Regents Of The University Of California | Engaging the cervical spinal cord circuitry to re-enable volitional control of hand function in tetraplegic subjects |
| EP3065636B1 (en) * | 2013-11-07 | 2023-08-30 | SafeOp Surgical, Inc. | Systems and methods for detecting nerve function |
| ES3033225T3 (en) * | 2013-11-15 | 2025-07-31 | Closed Loop Medical Pty Ltd | Monitoring brain neural potentials |
| CN105848574B9 (zh) | 2013-11-22 | 2020-01-21 | 萨鲁达医疗有限公司 | 用于检测神经测量值中的神经反应的方法和装置 |
| CN109432596B (zh) | 2013-12-22 | 2022-05-17 | 纽约城市大学研究基金会 | 经脊髓直流电调节系统 |
| US9707391B2 (en) | 2013-12-22 | 2017-07-18 | The Research Foundation Of The City University Of New York | Method for modulation of effector organs |
| US9707390B2 (en) * | 2013-12-22 | 2017-07-18 | The Research Foundation Of The City University Of New York | Apparatus for modulation of effector organs |
| US20150217120A1 (en) | 2014-01-13 | 2015-08-06 | Mandheerej Nandra | Neuromodulation systems and methods of using same |
| WO2015143509A1 (en) | 2014-03-28 | 2015-10-01 | Saluda Medical Pty Ltd | Assessing neural state from action potentials |
| AU2015255631B2 (en) | 2014-05-05 | 2020-02-06 | Saluda Medical Pty Ltd | Improved neural measurement |
| WO2015187712A1 (en) * | 2014-06-02 | 2015-12-10 | Cala Health, Inc. | Systems and methods for peripheral nerve stimulation to treat tremor |
| AU2015292272B2 (en) | 2014-07-25 | 2020-11-12 | Saluda Medical Pty Ltd | Neural stimulation dosing |
| KR101523715B1 (ko) * | 2014-07-30 | 2015-05-29 | 한국과학기술연구원 | 하이브리드 자극을 이용한 생체 신경 기능 조절 시스템 |
| KR101465593B1 (ko) * | 2014-09-03 | 2014-11-27 | (주)와이브레인 | 경두개 직류 자극(tDCS) 장치 |
| CN104436447B (zh) * | 2014-10-11 | 2017-01-11 | 中国科学院苏州生物医学工程技术研究所 | 一种用于脊髓功能调控的闭环光刺激系统 |
| WO2016077882A1 (en) | 2014-11-17 | 2016-05-26 | Saluda Medical Pty Ltd | Method and device for detecting a neural response in neural measurements |
| WO2016090420A1 (en) | 2014-12-11 | 2016-06-16 | Saluda Medical Pty Ltd | Implantable electrode positioning |
| AU2015362091B2 (en) | 2014-12-11 | 2020-11-26 | Saluda Medical Pty Ltd | Method and device for feedback control of neural stimulation |
| KR101653889B1 (ko) | 2014-12-31 | 2016-09-09 | 영남대학교 산학협력단 | 능동형 생체이식 경천추 경막외 척수신경 자극을 위한 카테터용 박동성 고주파 자극장치 |
| KR101653888B1 (ko) | 2014-12-31 | 2016-09-02 | 영남대학교 산학협력단 | 수동형 생체이식 경천추 경막외 척수신경 자극을 위한 카테터용 박동성 고주파 자극장치 |
| EP3229893B1 (en) | 2015-01-19 | 2020-06-17 | Saluda Medical Pty Ltd | Method and device for neural implant communication |
| US9962547B2 (en) | 2015-02-05 | 2018-05-08 | Stimgenics, Llc | Method and apparatus for multimodal electrical modulation of pain |
| US10195424B2 (en) * | 2015-02-20 | 2019-02-05 | The Research Foundation Of The City University Of New York | Methods and systems for treatment of spinal disorders using trans-spinal direct current stimulation |
| US11077301B2 (en) | 2015-02-21 | 2021-08-03 | NeurostimOAB, Inc. | Topical nerve stimulator and sensor for bladder control |
| US10434311B2 (en) | 2015-03-20 | 2019-10-08 | Stimgenics, Llc | Method and apparatus for multimodal electrical modulation of pain |
| US10675466B2 (en) | 2015-03-20 | 2020-06-09 | Stimgenics, Llc | Method and apparatus for multimodal electrical modulation of pain using composite electromagnetic fields |
| US11167139B2 (en) | 2015-03-20 | 2021-11-09 | Medtronic Sg, Llc | Method and apparatus for multi modal electrical modulation of pain using composite electromagnetic fields |
| US12311177B2 (en) | 2015-03-20 | 2025-05-27 | Medtronic Sg, Llc | Method and apparatus for multi modal electrical modulation of pain using composite electromagnetic fields |
| US10850102B2 (en) | 2015-03-20 | 2020-12-01 | Medtronic Sg, Llc | Method and apparatus for multimodal electrical modulation of pain |
| CN107530543B (zh) | 2015-04-09 | 2021-03-02 | 萨鲁达医疗有限公司 | 电极到神经距离估计 |
| US11491342B2 (en) | 2015-07-01 | 2022-11-08 | Btl Medical Solutions A.S. | Magnetic stimulation methods and devices for therapeutic treatments |
| CA2983336C (en) | 2015-05-31 | 2024-05-28 | Saluda Medical Pty Ltd | Monitoring brain neural activity |
| CA2983333C (en) | 2015-05-31 | 2023-09-19 | Saluda Medical Pty Ltd | Brain neurostimulator electrode fitting |
| CN107613861B (zh) | 2015-06-01 | 2021-10-26 | 闭环医疗私人有限公司 | 运动纤维神经调节 |
| DE102015108861A1 (de) * | 2015-06-03 | 2016-12-08 | Cortec Gmbh | Verfahren und Vorrichtung zur Neurostimulation |
| EP4342516A3 (en) | 2015-06-10 | 2024-07-10 | Cala Health, Inc. | Systems and methods for peripheral nerve stimulation to treat tremor with detachable therapy and monitoring units |
| DE102015109988B4 (de) * | 2015-06-22 | 2017-04-27 | Forschungszentrum Jülich GmbH | Vorrichtung zur effektiven invasiven Zwei-Stufen-Neurostimulation |
| JP6796089B2 (ja) * | 2015-06-22 | 2020-12-02 | リサーチ ファウンデーション オブ ザ シティー ユニバーシティ オブ ニューヨークＲｅｓｅａｒｃｈ Ｆｏｕｎｄａｔｉｏｎ Ｏｆ Ｔｈｅ Ｃｉｔｙ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｎｅｗ Ｙｏｒｋ | 効果器を調節するための方法および装置 |
| US11266850B2 (en) | 2015-07-01 | 2022-03-08 | Btl Healthcare Technologies A.S. | High power time varying magnetic field therapy |
| US10695575B1 (en) | 2016-05-10 | 2020-06-30 | Btl Medical Technologies S.R.O. | Aesthetic method of biological structure treatment by magnetic field |
| US20180001107A1 (en) | 2016-07-01 | 2018-01-04 | Btl Holdings Limited | Aesthetic method of biological structure treatment by magnetic field |
| US10603482B2 (en) | 2015-09-23 | 2020-03-31 | Cala Health, Inc. | Systems and methods for peripheral nerve stimulation in the finger or hand to treat hand tremors |
| AU2016335931B2 (en) | 2015-10-06 | 2019-06-27 | Case Western Reserve University | High-charge capacity electrodes to deliver direct current nerve conduction block |
| US11036294B2 (en) | 2015-10-07 | 2021-06-15 | The Governing Council Of The University Of Toronto | Wireless power and data transmission system for wearable and implantable devices |
| US11253717B2 (en) | 2015-10-29 | 2022-02-22 | Btl Healthcare Technologies A.S. | Aesthetic method of biological structure treatment by magnetic field |
| US10864373B2 (en) | 2015-12-15 | 2020-12-15 | Case Western Reserve University | Systems for treatment of a neurological disorder using electrical nerve conduction block |
| CN108778411B (zh) | 2016-01-21 | 2022-06-03 | 卡拉健康公司 | 用来治疗与膀胱过动症相关的疾病的用于外周神经调制的系统、方法和装置 |
| ES2888773T3 (es) | 2016-04-05 | 2022-01-07 | Saluda Medical Pty Ltd | Control de retroalimentación de la neuromodulación mejorado |
| US11464993B2 (en) | 2016-05-03 | 2022-10-11 | Btl Healthcare Technologies A.S. | Device including RF source of energy and vacuum system |
| US11247039B2 (en) | 2016-05-03 | 2022-02-15 | Btl Healthcare Technologies A.S. | Device including RF source of energy and vacuum system |
| US11534619B2 (en) | 2016-05-10 | 2022-12-27 | Btl Medical Solutions A.S. | Aesthetic method of biological structure treatment by magnetic field |
| US10583287B2 (en) | 2016-05-23 | 2020-03-10 | Btl Medical Technologies S.R.O. | Systems and methods for tissue treatment |
| CN109561849B (zh) * | 2016-06-24 | 2023-01-13 | 萨鲁达医疗有限公司 | 伪像减少的神经刺激 |
| US10556122B1 (en) | 2016-07-01 | 2020-02-11 | Btl Medical Technologies S.R.O. | Aesthetic method of biological structure treatment by magnetic field |
| US10953230B2 (en) | 2016-07-20 | 2021-03-23 | The Governing Council Of The University Of Toronto | Neurostimulator and method for delivering a stimulation in response to a predicted or detected neurophysiological condition |
| CN109689156B (zh) | 2016-08-08 | 2023-08-01 | 深部脑刺激技术有限公司 | 用于监测神经活动的系统和方法 |
| US11141219B1 (en) | 2016-08-16 | 2021-10-12 | BTL Healthcare Technologies, a.s. | Self-operating belt |
| CN109803717B (zh) | 2016-08-25 | 2024-01-09 | 卡拉健康公司 | 通过周围神经刺激治疗心脏机能障碍的系统和方法 |
| EP3679979B1 (en) * | 2016-10-05 | 2021-06-16 | Tesla Medical s.r.o. | A device for neuromodulation treatment |
| WO2018101986A1 (en) | 2016-12-01 | 2018-06-07 | Thimble Bioelectronics, Inc. d/b/a Enso | Neuromodulation device and method for use |
| US20180272132A1 (en) | 2017-01-19 | 2018-09-27 | Nevro Corp. | High frequency stimulation for treating sensory and/or motor deficits in patients with spinal cord injuries and/or peripheral polyneuropathy, and associated systems and methods |
| US11235154B2 (en) | 2017-02-17 | 2022-02-01 | The University Of British Columbia | Apparatus and methods for maintaining physiological functions |
| CA3058786A1 (en) | 2017-04-03 | 2018-10-11 | Cala Health, Inc. | Systems, methods and devices for peripheral neuromodulation for treating diseases related to overactive bladder |
| WO2018187237A1 (en) | 2017-04-03 | 2018-10-11 | Presidio Medical, Inc. | Systems and methods for direct current nerve conduction block |
| US11298070B2 (en) | 2017-05-22 | 2022-04-12 | Deep Brain Stimulation Technologies Pty Ltd | Systems and methods for monitoring neural activity |
| WO2018217791A1 (en) | 2017-05-23 | 2018-11-29 | The Regents Of The University Of California | Accessing spinal networks to address sexual dysfunction |
| EP3974021B1 (en) | 2017-06-30 | 2023-06-14 | ONWARD Medical N.V. | A system for neuromodulation |
| WO2019050896A2 (en) * | 2017-09-05 | 2019-03-14 | University Of Florida Research Foundation, Inc. | STIMULATION OF NEURONES MOTORS OF SPINAL CORD BY ELECTRICAL SIGNALS |
| EP3691744B1 (en) * | 2017-10-04 | 2021-07-28 | Boston Scientific Neuromodulation Corporation | Adjustment of stimulation in a stimulator using detected evoked compound action potentials |
| WO2019094365A1 (en) | 2017-11-07 | 2019-05-16 | Neurostim Oab, Inc. | Non-invasive nerve activator with adaptive circuit |
| US11986645B2 (en) | 2017-11-07 | 2024-05-21 | Neurostim Technologies Llc | Restless legs syndrome treatment system |
| EP3720338B1 (en) | 2017-12-05 | 2025-09-24 | Ecole Polytechnique Fédérale de Lausanne (EPFL) | A system for planning and/or providing neuromodulation |
| US12357828B2 (en) | 2017-12-05 | 2025-07-15 | Ecole Polytechnique Federale De Lausanne (Epfl) | System for planning and/or providing neuromodulation |
| EP3740274A4 (en) | 2018-01-17 | 2021-10-27 | Cala Health, Inc. | SYSTEMS AND METHODS FOR TREATING INFLAMMATORY INTESTINAL DISEASE USING PERIPHERAL NERVE STIMULATION |
| US12465260B2 (en) | 2018-02-09 | 2025-11-11 | Presidio Medical, Inc. | Systems and methods for cardiac conduction block |
| CN119607410A (zh) | 2018-02-20 | 2025-03-14 | 普雷西迪奥医学有限公司 | 用于神经传导阻滞的方法和系统 |
| US11986659B2 (en) | 2018-03-22 | 2024-05-21 | Research Foundation Of The City University Of New York | Modulation of neuronal NKCC1 as a therapeutic strategy for spasticity and related disorders |
| US11617887B2 (en) * | 2018-04-19 | 2023-04-04 | University of Washington and Seattle Children's Hospital Children's Research Institute | Systems and methods for brain stimulation for recovery from brain injury, such as stroke |
| EP4434461A3 (en) | 2018-04-27 | 2025-03-05 | Saluda Medical Pty Ltd | Neurostimulation of mixed nerves |
| AU2019299334B2 (en) | 2018-07-01 | 2025-03-20 | Presidio Medical, Inc. | Systems and methods for nerve conduction block |
| CA3110463A1 (en) | 2018-08-23 | 2020-02-27 | The Regents Of The University Of California | Non-invasive spinal cord stimulation for nerve root palsy, cauda equina syndrome, and restoration of upper extremity function |
| CN109173056B (zh) * | 2018-10-19 | 2022-03-22 | 南通大学 | 一种大鼠脊髓神经信号检测与评估系统及方法 |
| DE18205817T1 (de) | 2018-11-13 | 2020-12-24 | Gtx Medical B.V. | Sensor in bekleidung von gliedmassen oder schuhwerk |
| KR102412194B1 (ko) * | 2018-11-13 | 2022-06-23 | 한국과학기술연구원 | 자폐 스펙트럼 장애의 치료방법, 자폐 스펙트럼 장애 모니터링용 마우스, 및 자폐 스펙트럼 장애 예방 또는 치료용 후보물질의 스크리닝 방법 |
| ES2911465T3 (es) | 2018-11-13 | 2022-05-19 | Onward Medical N V | Sistema de control para la reconstrucción y/o restauración del movimiento de un paciente |
| EP3695878B1 (en) | 2019-02-12 | 2023-04-19 | ONWARD Medical N.V. | A system for neuromodulation |
| DE202020005828U1 (de) | 2019-04-11 | 2022-09-06 | BTL Medical Solutions as. | Vorrichtungen zur Schönheitsbehandlung biologischer Strukturen durch Hochfrequenz- und Magnetenergie |
| US12156689B2 (en) | 2019-04-11 | 2024-12-03 | Btl Medical Solutions A.S. | Methods and devices for aesthetic treatment of biological structures by radiofrequency and magnetic energy |
| US11918811B2 (en) | 2019-05-06 | 2024-03-05 | Medtronic Sg, Llc | Method and apparatus for multi modal or multiplexed electrical modulation of pain using composite electromagnetic fields |
| CN110262336B (zh) * | 2019-06-18 | 2021-02-02 | 中国科学院自动化研究所 | 电流输出电路及包括其的经颅电刺激设备 |
| KR20220025834A (ko) | 2019-06-26 | 2022-03-03 | 뉴로스팀 테크놀로지스 엘엘씨 | 적응적 회로를 갖는 비침습적 신경 활성화기 |
| US12251560B1 (en) | 2019-08-13 | 2025-03-18 | Cala Health, Inc. | Connection quality determination for wearable neurostimulation systems |
| GB2591429A (en) * | 2019-09-06 | 2021-08-04 | Imp College Innovations Ltd | Apparatus and method |
| US11890468B1 (en) | 2019-10-03 | 2024-02-06 | Cala Health, Inc. | Neurostimulation systems with event pattern detection and classification |
| CA3159295A1 (en) | 2019-11-24 | 2021-05-27 | Douglas Michael Ackermann | Current bias as a control mechanism for electrode operation |
| EP4061476A4 (en) | 2019-11-24 | 2023-12-13 | Presidio Medical, Inc. | Pulse generation and stimulation engine systems |
| DE19211698T1 (de) | 2019-11-27 | 2021-09-02 | Onward Medical B.V. | Neuromodulation system |
| EP3827875B1 (en) | 2019-11-27 | 2023-07-05 | ONWARD Medical N.V. | Neuromodulation system |
| CN110946577A (zh) * | 2019-12-03 | 2020-04-03 | 南京航空航天大学 | 一种采集手臂肌电信号的柔性电路板装置 |
| JP2023506713A (ja) | 2019-12-16 | 2023-02-20 | ニューロスティム テクノロジーズ エルエルシー | 昇圧電荷送達を用いた非侵襲性神経アクティベータ |
| CN111481438A (zh) * | 2020-04-23 | 2020-08-04 | 四川大学华西医院 | 一种治疗脑出血继发性神经损伤的电针仪 |
| US11878167B2 (en) | 2020-05-04 | 2024-01-23 | Btl Healthcare Technologies A.S. | Device and method for unattended treatment of a patient |
| BR112022022112A2 (pt) | 2020-05-04 | 2022-12-13 | Btl Healthcare Technologies As | Dispositivo para tratamento não assistido do paciente |
| US12208266B2 (en) | 2020-05-26 | 2025-01-28 | Research Foundation Of The City University Of New York | Multi-site neuromodulation for treatment of ALS and related disorders |
| KR20220055231A (ko) | 2020-10-26 | 2022-05-03 | 주식회사 에이치엘메디텍 | 능동형 생체이식 경천추 경막외 척수신경 자극을 위한 카테터용 박동성 고주파 자극장치 |
| CA3200200A1 (en) * | 2020-12-03 | 2022-06-09 | REHABILITATION INSTITUTE OF CHICAGO d/b/a Shirley Ryan AbilityLab | Systems and methods for facilitating multisite paired corticospinal-motoneuronal stimulation therapy |
| CA3260012A1 (en) | 2021-10-13 | 2023-04-20 | Btl Medical Solutions A.S. | AESTHETIC TREATMENT DEVICES FOR BIOLOGICAL STRUCTURES USING RADIOFREQUENCY AND MAGNETIC ENERGY |
| US11896816B2 (en) | 2021-11-03 | 2024-02-13 | Btl Healthcare Technologies A.S. | Device and method for unattended treatment of a patient |
| KR102873191B1 (ko) | 2022-02-23 | 2025-10-17 | 충북대학교 산학협력단 | 중뇌수도관 주변 회백질 내 신경세포의 광유전학적 자극을 통한 삼차신경통 저해 방법 |
| KR102805604B1 (ko) | 2022-02-23 | 2025-05-09 | 충북대학교 산학협력단 | 전두대상피질 내 신경세포의 광유전학적 자극을 통한 좌골신경통 억제 방법 |
| CN114886545B (zh) * | 2022-05-07 | 2023-11-28 | 宇寿医疗科技(无锡)有限公司 | 一种同步双极性短脉冲肿瘤消融方法与装置 |
| CN114886546B (zh) * | 2022-05-09 | 2023-11-28 | 宇寿医疗科技(无锡)有限公司 | 一种同步双极性短脉冲肿瘤消融方法与系统 |
| US11986657B2 (en) | 2022-07-01 | 2024-05-21 | Nevro Corp. | Neurostimulation for treating sensory deficits, and associated systems and methods |
| CN117679636B (zh) * | 2023-12-25 | 2025-11-28 | 东南大学 | 一种抑郁症穿戴式颅内荷电弥散电刺激装置 |
| CN117653908B (zh) * | 2024-01-17 | 2024-05-28 | 湖北文理学院 | 一种基于电刺激的神经肌肉康复设备及其使用方法 |
| CN119113391B (zh) * | 2024-08-28 | 2025-05-06 | 北京领创医谷科技发展有限责任公司 | 向电极施加电流的方法和装置 |
| CN120437491A (zh) * | 2024-11-28 | 2025-08-08 | 西安穹顶医疗科技有限公司 | 极性可调的无创脑深部电刺激系统 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5047005A (en) * | 1987-01-28 | 1991-09-10 | Cadwell Industries, Inc. | Method and apparatus for magnetically stimulating neurons |
| US6839594B2 (en) * | 2001-04-26 | 2005-01-04 | Biocontrol Medical Ltd | Actuation and control of limbs through motor nerve stimulation |
| JP2004321242A (ja) * | 2003-04-21 | 2004-11-18 | Matsushita Electric Works Ltd | 脳脊髄液循環促進装置及び該方法並びにぼけ遅行装置 |
| US7422555B2 (en) * | 2003-12-30 | 2008-09-09 | Jacob Zabara | Systems and methods for therapeutically treating neuro-psychiatric disorders and other illnesses |
| US20060052836A1 (en) * | 2004-09-08 | 2006-03-09 | Kim Daniel H | Neurostimulation system |
| US20060116720A1 (en) * | 2004-12-01 | 2006-06-01 | Penny Knoblich | Method and apparatus for improving renal function |
| US7844340B2 (en) * | 2007-01-31 | 2010-11-30 | Pawlowicz Iii John S | Devices and methods for transcutaneous electrical neural stimulation |
| US7949403B2 (en) * | 2007-02-27 | 2011-05-24 | Accelerated Care Plus Corp. | Electrical stimulation device and method for the treatment of neurological disorders |
-
2011
- 2011-01-24 KR KR1020127027536A patent/KR101866252B1/ko not_active Expired - Fee Related
- 2011-01-24 US US13/635,929 patent/US20130035745A1/en not_active Abandoned
- 2011-01-24 MX MX2012010841A patent/MX2012010841A/es active IP Right Grant
- 2011-01-24 WO PCT/US2011/022283 patent/WO2011119251A2/en not_active Ceased
- 2011-01-24 CN CN201610029272.3A patent/CN105477782B/zh not_active Expired - Fee Related
- 2011-01-24 CA CA2829189A patent/CA2829189A1/en not_active Abandoned
- 2011-01-24 MX MX2015017515A patent/MX350386B/es unknown
- 2011-01-24 CN CN201180025486.9A patent/CN102905757B/zh not_active Expired - Fee Related
- 2011-01-24 JP JP2013501261A patent/JP5726285B2/ja active Active
-
2012
- 2012-09-20 IL IL222033A patent/IL222033A/en not_active IP Right Cessation
-
2015
- 2015-03-31 JP JP2015071611A patent/JP6062990B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| KR20130020669A (ko) | 2013-02-27 |
| JP2015123376A (ja) | 2015-07-06 |
| KR101866252B1 (ko) | 2018-06-11 |
| WO2011119251A3 (en) | 2011-12-22 |
| JP6062990B2 (ja) | 2017-01-18 |
| US20130035745A1 (en) | 2013-02-07 |
| JP2013521979A (ja) | 2013-06-13 |
| WO2011119251A2 (en) | 2011-09-29 |
| IL222033A (en) | 2015-07-30 |
| CN102905757A (zh) | 2013-01-30 |
| MX2012010841A (es) | 2013-01-29 |
| CA2829189A1 (en) | 2011-09-29 |
| MX350386B (es) | 2017-09-05 |
| CN105477782A (zh) | 2016-04-13 |
| CN105477782B (zh) | 2019-01-04 |
| CN102905757B (zh) | 2016-02-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6062990B2 (ja) | チャージ強化神経電気刺激システム | |
| US9821157B2 (en) | Charge-enhanced neural electric stimulation system | |
| Capogrosso et al. | Configuration of electrical spinal cord stimulation through real-time processing of gait kinematics | |
| Minassian et al. | Targeting lumbar spinal neural circuitry by epidural stimulation to restore motor function after spinal cord injury | |
| EP2776119B1 (en) | Transcutaneous spinal cord stimulation: noninvasive tool for activation of locomotor circuitry | |
| JP2021534877A (ja) | 神経根麻痺、馬尾症候群、及び上肢機能の回復のための非侵襲性脊髄刺激 | |
| Laczo et al. | Increasing human leg motor cortex excitability by transcranial high frequency random noise stimulation | |
| KR20140098780A (ko) | 운동, 감각, 자율적, 성적, 혈관운동 및 인식 기능의 복원을 가능하게 하기 위한 비침습성 신경조절 디바이스 | |
| Tator et al. | Spinal cord stimulation: therapeutic benefits and movement generation after spinal cord injury | |
| JP2013530747A (ja) | 空間選択的迷走神経刺激のためのシステム | |
| CN110121375A (zh) | 用于运动功能恢复的感觉信息顺应性脊髓刺激系统 | |
| Prochazka et al. | Activation and coordination of spinal motoneuron pools after spinal cord injury | |
| Harvey et al. | Cortical stimulation as an adjuvant to upper limb rehabilitation after stroke | |
| EP2550060B1 (en) | Charge-enhanced neural electric stimulation system | |
| Gad et al. | Electrophysiological mapping of rat sensorimotor lumbosacral spinal networks after complete paralysis | |
| US20250135201A1 (en) | Selective neurostimulation of peripheral nerves with reduced off-target activation | |
| Schmidt | Optogenetically mediated neuromodulation paired with exercised based rehabilitation in adult transected rats enhances voluntary control of trunk muscle segments below injury leading to alterations in spinal circuitry | |
| Musienko et al. | Initiation of locomotor activity in decerebrate and spinal cats using noninvasive transcutaneous electrical stimulation of the spinal cord | |
| MINASSIAN et al. | Activity after Spinal Cord Injury | |
| Posterior | KAREN MINASSIAN, URSULA HOFSTOETTER, AND FRANK RATTAY | |
| Pulverenti et al. | Abstract# 75: Transspinal Stimulation Mediated Spinal Neural Reflex Interactions | |
| Nguyen | Multi-input transcutaneous neuromuscular electrical stimulation for control of the lower limb | |
| Oza | Plasticity of trunk motor cortex as a result of spinal cord injury and robot rehabilitation training | |
| Zewdie | Neuronal mechanisms underlying retraining of walking after incomplete spinal cord injury | |
| Westheimer | Tapping into the Spinal Cord for Restoring Function After Spinal Cord Injury |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20140122 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20140122 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20140924 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20140930 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20141219 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20150203 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20150302 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20150331 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 5726285 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |